Literature DB >> 3936238

Ethnic heterogeneity in the distribution of the OKT4 antigen on lymphocytes: studies in three black families.

S Pahwa, C Sia, C Te, R Harper, R Pahwa.   

Abstract

Human T lymphocytes bear characteristic membrane antigens which allow for identification on these cells and their subpopulations with monoclonal antibody reagents directed against the specific cell-surface antigens. During a study of T lymphocyte subpopulations in a group of 41 infants from a high risk nursery, three of the seven black infants studied were found to be missing cells reactive with the monoclonal antibody OKT4 which identifies the helper-inducer subset of T cells. Immunological evaluation of these infants and study of their family members revealed that the OKT4 non-reactive lymphocytes reacted normally with another antibody, OKT4A, which also identifies the helper-inducer subset of T cells. The deficiency of the antigen recognized by the OKT4 antibody appeared not to reflect T cell immaturity and was not associated with obvious immunodeficiency. The OKT4 negative phenotype appeared to be transmitted in an autosomal recessive mode. Our studies suggest that heterozygosity for this phenotype is relatively common among the black population and that heterozygotes are not easily distinguishable from the random population on the basis of lymphocyte reactivity with the OKT4 monoclonal antibody.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936238

Source DB:  PubMed          Journal:  Thymus        ISSN: 0165-6090


  2 in total

1.  Polymorphism for RhT3, a CD3-like cell surface antigen, expressed on rhesus monkey T lymphocytes.

Authors:  F J Nooij; W van Vreeswijk; J Coolen
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

2.  Role of CD4 molecule in the induction of interleukin 2 and interleukin 2 receptor in class II major histocompatibility complex-restricted antigen-specific T helper clones. T cell receptor/CD3 complex transmits CD4-dependent and CD4-independent signals.

Authors:  N Oyaizu; N Chirmule; S Pahwa
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.